Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension
Glucocorticoid remediable aldosteronism (GRA) also known as familial hyperaldosteronism type 1 (FH1) is a rare genetic form of primary aldosteronism characterized by aldosterone overproduction regulated by adrenocorticotropic hormone (ACTH). We present the case of a 54-year-old woman with severe hypertension and hypokalemia. Genetic testing confirmed GRA by identifying a chimeric gene involving CYP11B1 and CYP11B2. This case highlights the importance of considering GRA in patients with resistant hypertension and a family history of cerebral aneurysms. Management involved glucocorticoid therapy and mineralocorticoid receptor antagonists, leading to significant improvement in blood pressure control.
Authors
- Crystal Kamilaris (ORCID: https://orcid.org/0000-0002-3872-0447)
- J Zeman (ORCID: https://orcid.org/0000-0002-2678-7919)
Institutions
- National Institutes of Health (US)
- University of Connecticut (US)
- Charles University (CZ)
- General University Hospital in Prague (CZ)
- UConn Health (US)
Publication Details
- Journal
- Prague Medical Report
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14712/23362936.2025.23
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00